Researchers at UK-based CARE Fertility have developed a test that can increase the chances of having a baby through in-vitro fertilisation (IVF).
Chromosomal abnormalities are a major cause of pregnancy failures, including those involving IVF.
The new test works by detecting chromosomal abnormalities present in the embryos before they are reimplanted.
A biopsy of the embryo’s placental cells is then performed and the chromosomes analysed for any abnormalities.
Using this information it is possible to select the embryos that will go on to achieve a successful pregnancy.
The test can double or triple IVF success rates, according to the trial’s researchers.
The clinical trials are being conducted at CARE Fertility in Manchester, UK.